Molecular origins of cancer: Lung cancer

By R. Herbst, J. Heymach, S. Lippman. 2008

1,714 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/fe9e80feeed93a1161f86dfa4adc78a61bd50bc1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. M. V. Vander Heiden
2. D. Y. Gui
3. Phillip A. Sharp
4. Alba Luengo
5. Robert Langer
6. Aviv Regev
7. T. Jacks
8. T. Papagiannakopoulos

In Molecular Biology

1. M. V. Vander Heiden
2. Phillip A. Sharp
3. Robert Langer
4. Daniel G. Anderson
5. D. Y. Gui
6. Alba Luengo
7. Aviv Regev
8. G. Feng

In Pulmonary and Respiratory Medicine

1. Phillip A. Sharp
2. M. V. Vander Heiden

Citations in the corpus

• CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling (2014, background): “The variation in tumor size suggests dynamic tumor initiation and growth across lobes and animals, which is reminiscent of the complexity observed in human tumors (Herbst et al., 2008).”
• Tumor Mutation Burden and Efficacy of Nivolumab Monotherapy and in Combination With Ipilimumab in Small Cell Lung Cancer (2018, neutral): “Small-cell lung cancer (SCLC) accounts for 10%–15% of all patients with lung cancer (Alvarado-Luna and Morales-Espinosa, 2016; Herbst et al., 2008), and approximately 75% of patients present with extensive-stage disease.”
• Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer (2016, background): “Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality (Herbst et al., 2008).”